Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phio Pharmaceuticals (PHIO)
NASDAQ:PHIO
PHIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.53 - $10.35
Previous CloseN/A
Volume62.29K
Average Volume (3M)12.46M
Market Cap
$8.22M
Enterprise Value-$1.97M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.20
Next Earnings
Mar 19, 2025EPS Estimate
-1.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.94
Shares Outstanding4,776,848
10 Day Avg. Volume250,766
30 Day Avg. Volume12,462,035
Standard Deviation0.24
R-Squared0.12
Alpha-0.09
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.24
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.31
Enterprise Value/Ebitda0.27
Forecast
1Y Price Target
$4.00Price Target Upside139.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Phio Pharmaceuticals News
PremiumCompany Announcements
Phio Pharmaceuticals Appoints David Deming to Board
---
Ownership Overview
1.27% Insiders
0.17% Mutual Funds
0.86% Other Institutional Investors
97.65% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
PHIO FAQ
What was Phio Pharmaceuticals’s price range in the past 12 months?
Phio Pharmaceuticals lowest stock price was $1.53 and its highest was $10.35 in the past 12 months.
What is Phio Pharmaceuticals’s market cap?
Phio Pharmaceuticals’s market cap is $8.22M.
When is Phio Pharmaceuticals’s upcoming earnings report date?
Phio Pharmaceuticals’s upcoming earnings report date is Mar 19, 2025 which is in 24 days.
How were Phio Pharmaceuticals’s earnings last quarter?
Phio Pharmaceuticals released its earnings results on Nov 14, 2024. The company reported -$1.54 earnings per share for the quarter, beating the consensus estimate of -$4.14 by $2.6.
Is Phio Pharmaceuticals overvalued?
According to Wall Street analysts Phio Pharmaceuticals’s price is currently Undervalued.
Does Phio Pharmaceuticals pay dividends?
Phio Pharmaceuticals does not currently pay dividends.
What is Phio Pharmaceuticals’s EPS estimate?
Phio Pharmaceuticals’s EPS estimate is -1.23.
How many shares outstanding does Phio Pharmaceuticals have?
Phio Pharmaceuticals has 4,776,848 shares outstanding.
What happened to Phio Pharmaceuticals’s price movement after its last earnings report?
Phio Pharmaceuticals reported an EPS of -$1.54 in its last earnings report, beating expectations of -$4.14. Following the earnings report the stock price went down -0.897%.
Which hedge fund is a major shareholder of Phio Pharmaceuticals?
Currently, no hedge funds are holding shares in PHIO
---
Company Description
Phio Pharmaceuticals
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
---
PHIO Stock 12 Month Forecast
Average Price Target
$4.00
▲(139.52% Upside)
Technical Analysis
Best Analysts Covering PHIO
1 Year
1 Year Success Rate
0/16 ratings generated profit
1 Year Average Return
-61.19%
reiterated a buy rating 5 days ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -61.19% per trade.
---